Cancer chemotherapy-induced lactose malabsorption in children.
To determine whether lactose malabsorption can be induced in children receiving cancer chemotherapy, lactose breath hydrogen tests (LBHT) were performed on 27 patients (ages 2 months to 16 10/12 years, mean 4 3/12 years) with neoplastic disease. Nine patients had an LBHT before their first course of chemotherapy and then 7--26 days afterwards. Eighteen other patients, less than 5 years old and presumed by virtue of age to be normal lactose absorbers, had an LBHT 7--24 days after their last course of chemotherapy. All nine in the first group had a normal LBHT before chemotherapy, and three had an abnormal LBHT 7--21 days later. Six of eighteen patients in the second group had an abnormal LBHT. Of the nine patients with an abnormal LBHT, six had a history of diarrhea associated with chemotherapy. These findings have important implications for children receiving cancer chemotherapy. High-calorie, milk-containing solutions used in nutritional support may precipitate cramps and diarrhea in some of these patients. A therapeutic trial of a low lactose diet in children in whom diarrhea develops during chemotherapy may be indicated.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001944:Breath Tests; D002648:Child; D002675:Child, Preschool; D003967:Diarrhea / Q000139:chemically induced; D004032:Diet; D006801:Humans; D007223:Infant; D007785:Lactose / Q000008:administration & dosage / Q000378:metabolism*; D007958:Leukocyte Count; D008286:Malabsorption Syndromes / Q000139:chemically induced*; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D007785:Lactose